ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more
Market Cap & Net Worth: ORTOMA AB B (82Y)
ORTOMA AB B (F:82Y) has a market capitalization of $24.72 Million (€24.09 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #25803 globally and #2814 in its home market, demonstrating a -7.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ORTOMA AB B's stock price €0.68 by its total outstanding shares 35419731 (35.42 Million).
ORTOMA AB B Market Cap History: 2021 to 2026
ORTOMA AB B's market capitalization history from 2021 to 2026. Data shows change from $90.53 Million to $24.72 Million (-23.65% CAGR).
ORTOMA AB B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ORTOMA AB B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 82Y by Market Capitalization
Companies near ORTOMA AB B in the global market cap rankings as of March 19, 2026.
Key companies related to ORTOMA AB B by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
ORTOMA AB B Historical Marketcap From 2021 to 2026
Between 2021 and today, ORTOMA AB B's market cap moved from $90.53 Million to $ 24.72 Million, with a yearly change of -23.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €24.72 Million | -44.03% |
| 2025 | €44.17 Million | +62.00% |
| 2024 | €27.27 Million | -12.79% |
| 2023 | €31.27 Million | -16.10% |
| 2022 | €37.27 Million | -58.84% |
| 2021 | €90.53 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of ORTOMA AB B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.72 Million USD |
| MoneyControl | $24.72 Million USD |
| MarketWatch | $24.72 Million USD |
| marketcap.company | $24.72 Million USD |
| Reuters | $24.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.